79 related articles for article (PubMed ID: 8704425)
1. [Relationship between anti-coagulation system changes of coronary heart disease patients and different syndrome-type in TCM].
Liang TJ; Gao SZ; Zhang FL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):599-600. PubMed ID: 8704425
[TBL] [Abstract][Full Text] [Related]
2. [Relation of coronary heart disease based on traditional Chinese medicine syndrome differentiation and prostaglandin, blood platelet function, and protein C].
Guo XC
Zhong Xi Yi Jie He Za Zhi; 1991 May; 11(5):263-4, 259. PubMed ID: 1831734
[TBL] [Abstract][Full Text] [Related]
3. [Study on changes of TCM syndrome in patients with coronary heart disease before and after intervention treatment].
Chen BJ; Pan ZQ; Su XX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):689-91. PubMed ID: 17879529
[TBL] [Abstract][Full Text] [Related]
4. Protein C, S and antithrombin III levels in patients with acute mechanical valve thrombosis.
Tütün U; Ulus AT; Aksöyek A; Kaplan S; Ayaz S; Yilmaz S; Birincioglu L; Katircioglu SF
Panminerva Med; 2002 Dec; 44(4):359-63. PubMed ID: 12434119
[TBL] [Abstract][Full Text] [Related]
5. [Study on blood coagulant/fibrinolytic activity at plasma and monocytic levels in coronary heart disease patients with Blood-Stasis Syndrome of traditional Chinese medicine].
Lu Z; Shi S
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jun; 20(6):418-20. PubMed ID: 11789222
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary study on relationship between TCM syndrome-type and insulin resistance in coronary heart disease].
Mao W; Ye W; Liu Q
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Sep; 21(9):657-9. PubMed ID: 12575550
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between syndrome factor combination and cardiac function as well as blood-lipid in coronary heart disease].
Wang J; He QY; Shi Z; Xing YW; Li J; Fang YT; Tang YL
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):897-901. PubMed ID: 18782530
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between Chinese medicine syndrome and serum level of high-sensitivity C-reactive protein in patients with stable coronary heart disease].
Zheng F; Qu D; Xu H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jun; 29(6):485-8. PubMed ID: 19702076
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis.
Yang N; Hao J; Zhang D
J Int Med Res; 2017 Feb; 45(1):147-158. PubMed ID: 28222624
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease.
Nalçaci M; Pekçelen Y
J Int Med Res; 1998; 26(4):206-8. PubMed ID: 9818787
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human soluble thrombomodulin delivers bounded thrombin to antithrombin III: thrombomodulin associates with free thrombin and is recycled to activate protein c.
Aritomi M; Watanabe N; Ohishi R; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):418-22. PubMed ID: 8259541
[TBL] [Abstract][Full Text] [Related]
12. Buyang Huanwu decoction ameliorates coronary heart disease with Qi deficiency and blood stasis syndrome by reducing CRP and CD40 in rats.
Zhang H; Wang WR; Lin R; Zhang JY; Ji QL; Lin QQ; Yang LN
J Ethnopharmacol; 2010 Jul; 130(1):98-102. PubMed ID: 20420893
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities in thrombin-antithrombin pathway in AL amyloidosis.
Gamba G; Montani N; Anesi E; Palladini G; Lorenzutti F; Perfetti V; Merlini G
Amyloid; 1999 Dec; 6(4):273-7. PubMed ID: 10611948
[TBL] [Abstract][Full Text] [Related]
14. Effect of hemodialysis on protein C, protein S, and antithrombin III levels.
Lai KN; Yin JA; Yuen PM; Li PK
Am J Kidney Dis; 1991 Jan; 17(1):38-42. PubMed ID: 1824735
[TBL] [Abstract][Full Text] [Related]
15. [Exploring into relationship between serum lipoprotein electrophoretogram and the differentiation as phlegm stasis syndrome of aged coronary heart disease patients].
Zhang M; Liang D; Zeng Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Mar; 19(3):155-8. PubMed ID: 11783283
[TBL] [Abstract][Full Text] [Related]
16. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
[TBL] [Abstract][Full Text] [Related]
17. Effect of desmopressin on protein S and antithrombin III in uremia.
Akpolat T; Eser M; Albayrak D; Arik N
Nephron; 1997; 77(3):362. PubMed ID: 9375836
[No Abstract] [Full Text] [Related]
18. Decreased protein S activity in sickle cell disease.
Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
[TBL] [Abstract][Full Text] [Related]
19. Study of protein C, protein S, and antithrombin III in newborns with sepsis.
El Beshlawy A; Alaraby I; Abou Hussein H; Abou-Elew HH; Mohamed Abdel Kader MS
Pediatr Crit Care Med; 2010 Jan; 11(1):52-9. PubMed ID: 19924026
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling of protein C and antithrombin III activity in cerebral ischemia patients associated with cutis marmorata.
Li TH; Chen TH; Lin HS; Liou CW; Liu JS; Chen SS; Chen WH
Acta Neurol Taiwan; 2008 Dec; 17(4):233-8. PubMed ID: 19280866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
